Variant report
Variant | esv3407480 |
---|---|
Chromosome Location | chr11:120694163-120694633 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565749280 | chr11:120694173-120694174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs117947483 | chr11:120694228-120694229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75954141 | chr11:120694254-120694255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546807270 | chr11:120694272-120694273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs118087878 | chr11:120694321-120694322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181245562 | chr11:120694344-120694345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557250830 | chr11:120694390-120694391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs148984434 | chr11:120694408-120694409 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568848759 | chr11:120694412-120694413 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535852200 | chr11:120694434-120694435 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554685212 | chr11:120694440-120694441 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572843525 | chr11:120694447-120694448 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143747355 | chr11:120694456-120694457 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542359287 | chr11:120694460-120694461 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12278293 | chr11:120694461-120694462 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs75208530 | chr11:120694466-120694467 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537735457 | chr11:120694475-120694476 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11827443 | chr11:120694502-120694503 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs530134301 | chr11:120694507-120694508 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112891502 | chr11:120694522-120694523 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11218015 | chr11:120694523-120694524 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs560673746 | chr11:120694526-120694527 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs111543826 | chr11:120694531-120694532 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12291645 | chr11:120694571-120694572 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs549550224 | chr11:120694587-120694588 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532311192 | chr11:120694597-120694598 | Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Developmental delay | 21147756 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Acute lymphoblastic leukemia | 22581003 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Cancer | 21183584 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Neurocytoma | 17123091 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 20409316 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Heart disease | 20551144 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Autism | 22543975 | CNVD |
Breast cancer | 21509527 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:120674000-120696000 | Weak transcription | Fetal Lung | lung |
2 | chr11:120680200-120695000 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr11:120684000-120707600 | Weak transcription | Ovary | ovary |
4 | chr11:120688200-120699800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
5 | chr11:120688400-120695200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr11:120688600-120698400 | Weak transcription | Brain Hippocampus Middle | brain |
7 | chr11:120690800-120698600 | Weak transcription | Brain Cingulate Gyrus | brain |
8 | chr11:120691400-120699000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr11:120691600-120698800 | Weak transcription | Brain Anterior Caudate | brain |
10 | chr11:120693600-120694200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr11:120693600-120694600 | Enhancers | HepG2 | liver |
12 | chr11:120694200-120694600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr11:120694400-120694600 | Flanking Bivalent TSS/Enh | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr11:120694400-120694600 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
15 | chr11:120694600-120696000 | Weak transcription | HepG2 | liver |
16 | chr11:120694600-120703000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |